Albatroz Therapeutics operates as a biotechnology company.
Albatroz Therapeutics has raised $3.0M in total funding. The most recent round was Seed. The last funding was announced in April 2023.
Albatroz Therapeutics's investors include Seeds Capital, Outram Bio.
Albatroz Therapeutics is headquartered in Singapore, Singapore.
Albatroz Therapeutics operates as a biotechnology company.
Albatroz Therapeutics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Albatroz Therapeutics — Funding & Investors." VCBacked, April 25, 2023, https://www.vcbacked.co/company/albatroz-therapeutics. Accessed September 30, 2026.
VCBacked. (2023). Albatroz Therapeutics — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/albatroz-therapeutics
{{cite web |title=Albatroz Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/albatroz-therapeutics |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated